Location will support infertility patients from Springfield, Union, Westfield, Cranford, Kenilworth and all across Union and Essex Counties
(BASKING RIDGE, NJ – Aug. 1) – On August 15, Reproductive Medicine Associates of New Jersey (RMANJ), a world-renowned leader in the field of infertility, will welcome patients to its newest location in Springfield, New Jersey, located at 955 S. Springfield Avenue, Building A. Patient appointments can be made by calling (973) 656-2089, Monday through Friday, from 7 a.m. to 5 p.m., or online at www.rmanj.com.
“We’re very excited to have a new and spacious office in Springfield. While our patients come to us knowing that our fertility treatments are well validated and our IVF success rates are well above the U.S. average, they still want the convenience of early morning hours and easily accessible offices,” said Shefali Shastri, MD, an attending physician at RMANJ. “I live in the area, and whether I bump into patients at the local Trader Joe’s or meet with them at our new offices, I’m reminded each day what a privilege it is to be part of this community.”
“Patients are excited for our new Springfield office to open and we are too,” said Marcus Jurema, MD, FACOG, attending physician RMANJ. “Infertility care requires a major commitment of time and resources, and we believe that our Springfield office’s central location and early hours can help reduce the impact of both on our patients.”
With current IVF delivery rates of 63.2 %, RMANJ supports hopeful patients with the widest range of services, including in vitro fertilization (IVF), egg donation, gestational surrogacy, comprehensive chromosome screening (CCS), pre-implantation genetic diagnosis (PGD), fertility preservation services, acupuncture, yoga and patient-to-patient networking.
Additionally, RMANJ’s Springfield office will offer the CareShare 100% Refund Program, which will provide eligible patients with up to six stimulated in vitro fertilization (IVF) cycles and the use of frozen embryo transfer (FET) in order to achieve one successful pregnancy that culminates with a live birth and birth certificate. Eligibility for the program is based on clinical and other criteria.
Dr. Jurema also provided additional recommendations and insights about when to seek infertility care. “More than seven million men and women in the US are equally impacted by infertility – about 12 percent of the reproductive age population. According to the American Society for Reproductive Medicine, prospective patients should seek the care of a reproductive specialist if they are unable to achieve pregnancy after 12 months of unprotected intercourse, and if the woman is between 35 and 35 ½ years of age.
RMANJ’s new office will be located at 955 S. Springfield Avenue, Building A, Springfield, NJ 07081. Patient appointments can be made by calling (973) 656-2089, Monday through Friday 7am-5pm or by visiting www.rmanj.com.
The experts at RMANJ offer IVF delivery rates of 63.2% percent in women under 35 (n=886) and well above the US average*. Since 1999, they have helped bring nearly 40,000 babies to loving families. RMANJ has 22 physicians and ten locations in New Jersey: Basking Ridge, Eatontown, Englewood, Freehold, Hamilton, Marlton, Morristown, Somerset, Springfield, and West Orange. For more information, please call 973-656-2089 or visit www.rmanj.com.
RMANJ pioneered and successfully implemented a cutting-edge technology known as Select Comprehensive Chromosome Screening (SelectCCS) to more accurately detect healthy embryos that has led to successful pregnancies and ultimately healthy babies. SelectCCS is owned and operated by the Foundation for Embryonic Competence (www.feclabs.org), and offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.
*SART 2014; Cumulative Outcome per Intended Retrieval; Preliminary Chance of Live Birth per Cycle. Please note: A comparison of clinic success rates may not be meaningful because a patient’s medical characteristics, treatment approaches and entrance criteria for assisted reproductive technology (ART) may vary from clinic to clinic. Visit www.sart.org to learn more.